Search PubMed⌕ Search

Biomedical subjects

Y Kosaka

Publications and source records attributed to Y Kosaka.

At least 181 records · Page 10Linked to original sources
PubMed1987

Identification of the structures of multiple subspecies of protein kinase C expressed in rat brain.

Rat brain protein kinase C purified to apparent homogeneity [(1986) Biochem. Biophys. Res. Commun. 135, 636-643] was resolved into three distinct fractions, type I, II and III, upon chromatography on a hydroxyapatite column connected to high-performance liquid chromatography. Comparison of each fraction with the four subspecies of protein kinase C, that were separately expressed in COS cells transfected by the respective cDNAs, alpha, beta I, beta II and d gamma, identified the primary structures of these three fractions of protein kinase C. Type I corresponded to the enzyme encoded by the gamma-sequence; type II was a mixture of the two subspecies determined by the beta I- and beta II-sequences; and type III had the structure encoded by the alpha-sequence. The structures and properties of these subspecies of protein kinase C were similar to each other.

Animals↗
PubMed1987

Oxatomide inhibits the release of bronchoconstrictor arachidonic acid metabolites (iLTC4 and PGD2) from rat mast cells and guinea-pig lung.

The effect of oxatomide, an orally active antiallergic drug, on immunoreactive LTC4 (iLTC4) production has been studied in rat peritoneal exudate cells (PEC) and guinea-pig lung fragments using the calcium ionophore A23187 and specific antigen in vitro. Oxatomide (10(-5) M) inhibited iLTC4 release by 70% with A23187 from rat PEC, and by 48% with antigen from guinea-pig lung. Oxatomide is supposed to affect the biosynthesis pathway of leukotrienes, because oxatomide inhibits 5-lipoxygenase from guinea-pig peritoneal leukocytes with an IC50 17 microM. Oxatomide also depressed the release of PGD2 from rat peritoneal mast cells stimulated by A23187 (IC50 4.2 microM). The effects of oxatomide on iLTC4 and PGD2 release were more potent than other antiallergic drugs (DSCG, ketotifen, tranilast).

Animals↗
PubMed1987

Effects of ranitidine on plasma clearance of indocyanine green in patients with liver cirrhosis.

The effects of ranitidine on plasma clearance of ICG were investigated in 68 cirrhotic patients (9 were positive for HBsAg, 33 were alcoholics and 26 had cryptogenic cirrhosis). The ICG clearance test was performed before and after ranitidine administration. In 31 patients treated with ranitidine (150 mg perorally), the plasma ICG clearance were 233.6 +/- 20.4 ml/min (mean +/- S.E.) and 239.2 +/- 20.5 ml/min before and after ranitidine, respectively. In the 37 treated with intravenous ranitidine 50 mg, the corresponding values were 205.4 +/- 17.7 ml/min and 206.4 +/- 17.9 ml/min. There was no significant change in the plasma clearance of ICG or the elimination rate constant after ranitidine administration. Even in patients with decompensated liver cirrhosis, no significant change was demonstrated in the plasma ICG clearance after ranitidine. These results led to the conclusions that ranitidine does not reduce the hepatic blood flow and that it is a safe and useful drug for the treatment of gastrointestinal tract bleeding in patients with liver cirrhosis.

Adult↗
PubMed1987

Blood levels of mepivacaine during continuous epidural anesthesia.

Venous blood concentrations of mepivacaine were measured in 30 patients during 5 hr of surgical anesthesia following either multiple epidural injections of mepivacaine with or without epinephrine or continuous epidural infusion of mepivacaine with epinephrine. Patients were divided into three groups: group 1 initially received 10 or 15 ml followed by 10 ml of 2% plain mepivacaine at 1-hr intervals; group 2 received 10 or 15 ml followed by 10 ml of epinephrine-containing 2% mepivacaine at 1-hr intervals; group 3 received 10 or 15 ml followed by a constant infusion of 10 ml/hr of epinephrine-containing 2% mepivacaine. There were no significant differences between groups 1 and 2, but the mean blood concentration was slightly lower for the first 3 hr in group 2 than group 1. The mean blood concentration of mepivacaine in group 3 remained significantly lower than the concentrations in groups 1 and 2 from 3.5 to 5 hr. These results demonstrate that the blood concentrations of mepivacaine are not reduced by the addition of epinephrine to mepivacaine solutions when intermittent epidural injections are repeated more than four times at 1-hr intervals, but that blood mepivacaine levels are reduced below levels seen with intermittent injections by the continuous epidural infusion of epinephrine-containing mepivacaine.

Adult↗
PubMed1986

Mallory body formation and amyloid deposition in the liver of aged mice fed a vitamin A deficient diet for a prolonged period.

When twenty Swiss albino mice (male) were fed a vitamin A deficient diet for 18-24 months, Mallory bodies (MB(s] were observed. MBs were found by light microscopy and electron microscopy in the hepatocytes of six mice fed the vitamin A deficient diet and in one of the 15 control mice. Coincidentally, amyloid deposits were found in the space of Disse in the livers of 8 mice fed the deficient diet (three of the six mice with MBs). Amyloid was seen in two control mice suggesting that vitamin A enhanced amyloid deposition and MB formation in aging mice which spontaneously form amyloid and MBs. The possible role of vitamin A deficiency in the pathogenesis of MB formation is briefly discussed.

Aging↗